SPC Harmonisation
Guidance on SPC Harmonisation - according to Articles 70 to 72 of Regulation (EU) 2019/6
Best Practice Guide for the selection of the products for the SPC harmonisation
Best Practice Guide for the harmonisation procedure of the SPC of the reference products
Request form for proposing a veterinary medicinal product for SPC harmonisation
According to Article 69-72 of Regulation (EU) 2019/6, National Competent Authorities (NCA) as well as Marketing Authorisation Holders (MAH) may propose harmonisation of the SPCs of Reference Veterinary Medicinal Products (RVMPs) for which a marketing authorisation has been granted in accordance with Article 47.
The CMDv shall, annually, draw up a list of reference VMPs which shall be subject to SPC harmonisation and the CMDv shall also appoint a reference Member State (RMS) for each VMP concerned.
In case of interest in participation, the form (published on an annual basis) can be filled by MAHs willing to participate to the SPC harmonisation procedure in spring until the end of May. MAHs are advised to consult the CMDv website regularly for the publication of the form.
Any question can be raised to the CMDv secretariat (CMDv). @ ema.europa .eu
Products for SPC harmonisation 2023
The list of veterinary medicinal products that will be subject to the SPC harmonisation exercise for 2023 was endorsed by the CMDv and the HMA. The products are listed in the following table. The procedures will start according to timetables agreed between the MAH and the RMS.
The result of the SPC harmonisation procedure will be published in the CMDv website in due time once the procedures would have ended.
Name of VMP | Name of the active substance | Name of MAH | RMS proposed |
Catosal | Butafosfan, Cyanocobalamin | Elanco | DE-BVL |
Finadyne | Flunixine meglumine | Merck | ES |
Estrumate | Cloprostenol | Intervet | FR |
Domosedan | Detomidine hydrochloride | Orion | IE |
Planate | Cloprostenol | Merck | NL |